Literature DB >> 1287183

Mechanisms of intestinal absorption of the antibiotic, fosfomycin, in brush-border membrane vesicles in rabbits and humans.

T Ishizawa1, S Sadahiro, K Hosoi, I Tamai, T Terasaki, A Tsuji.   

Abstract

In order to clarify the mechanism of intestinal absorption of an antibiotic, fosfomycin (FOM), the uptakes of FOM by rabbit and human small intestinal brush-border membrane vesicles (BBMV) were studied. The initial uptake of FOM by BBMV at 15 s was saturable at a higher concentration of FOM. The kinetic parameters at 37 degrees C of the saturable uptake expressed by the Michaelis-Menten equation were Kt = 5.17 mM and Jmax = 3.88 nmol/15 s/mg protein for rabbits, and Kt = 4.03 mM and Jmax = 1.90 nmol/15 s/mg protein for humans. The most efficient uptake was observed in the presence of both inward-directed Na(+)- and H(+)-gradients in both mammals. The uptake of FOM was inhibited by inorganic phosphate, FOM glycol which is a degradation product of FOM in the gastric juice and specific inhibitors of phosphate transport such as arsenate and phosphonoacetic acid. These findings confirmed that FOM absorption from rabbit and human small intestines is associated with the phosphate transport system. These transport phenomena of FOM are in close agreement with those obtained previously in rat BBMV studies. Judging from the results obtained for three mammalian species, rat, rabbit and human, it was concluded that carrier-mediated transport via the phosphate transport system is a very important pathway of intestinal absorption of FOM.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1287183     DOI: 10.1248/bpb1978.15.481

Source DB:  PubMed          Journal:  J Pharmacobiodyn        ISSN: 0386-846X


  7 in total

1.  Pharmacokinetics, Safety, and Tolerability of Single-Dose Intravenous (ZTI-01) and Oral Fosfomycin in Healthy Volunteers.

Authors:  E Wenzler; E J Ellis-Grosse; K A Rodvold
Journal:  Antimicrob Agents Chemother       Date:  2017-08-24       Impact factor: 5.191

Review 2.  Carrier-mediated intestinal transport of drugs.

Authors:  A Tsuji; I Tamai
Journal:  Pharm Res       Date:  1996-07       Impact factor: 4.200

3.  Application of fractal kinetics for carrier-mediated transport of drugs across intestinal epithelial membrane.

Authors:  T Ogihara; I Tamai; A Tsuji
Journal:  Pharm Res       Date:  1998-04       Impact factor: 4.200

4.  IV and oral fosfomycin pharmacokinetics in neonates with suspected clinical sepsis.

Authors:  Zoe Kane; Silke Gastine; Christina Obiero; Phoebe Williams; Sheila Murunga; Johnstone Thitiri; Sally Ellis; Erika Correia; Borna Nyaoke; Karin Kipper; John van den Anker; Mike Sharland; James A Berkley; Joseph F Standing
Journal:  J Antimicrob Chemother       Date:  2021-06-18       Impact factor: 5.790

Review 5.  Fosfomycin: Pharmacological, Clinical and Future Perspectives.

Authors:  Anneke Corinne Dijkmans; Natalia Veneranda Ortiz Zacarías; Jacobus Burggraaf; Johan Willem Mouton; Erik Bert Wilms; Cees van Nieuwkoop; Daniel Johannes Touw; Jasper Stevens; Ingrid Maria Catharina Kamerling
Journal:  Antibiotics (Basel)       Date:  2017-10-31

6.  Penetration of fosfomycin into IPEC-J2 cells in the presence or absence of deoxynivalenol.

Authors:  Guadalupe Martínez; Denisa S Pérez; Alejandro L Soraci; María O Tapia
Journal:  PLoS One       Date:  2013-09-06       Impact factor: 3.240

7.  Fosfomycin as a potential therapy for the treatment of systemic infections: a population pharmacokinetic model to simulate multiple dosing regimens.

Authors:  Natalia V Ortiz Zacarías; Anneke C Dijkmans; Jacobus Burggraaf; Johan W Mouton; Erik B Wilms; Cees van Nieuwkoop; Daan J Touw; Ingrid M C Kamerling; Jasper Stevens
Journal:  Pharmacol Res Perspect       Date:  2018-02
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.